Skip to main content
    V

    vTv Therapeutics Inc (VTVT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $17.69
    -2.00 (-10.16%)

    Market Cap: $78.99M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    vTv Therapeutics Inc (VTVT) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to vTv Therapeutics are Tiziana Life Sciences (TLSA), Tenaya Therapeutics (TNYA) and Unicycive Therapeutics (UNCY). By market cap, vTv Therapeutics ranks 7th of the 13 companies on this page; Voyager Therapeutics (VYGR) is the largest at $107.66M.

    Peer Comparison

    VTVT's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    vTv Therapeutics (VTVT)$78.99MN/AN/A-20.8%N/A0.0%0.00%
    Tiziana Life Sciences Ltd (TLSA)$72.53MN/AN/A0.0%N/A0.0%0.00%
    Tenaya Therapeutics Inc (TNYA)$79.59MN/AN/A0.0%N/A0.0%0.00%
    Unicycive Therapeutics Inc (UNCY)$97.25MN/AN/A0.0%N/A0.0%0.00%
    Tenax Therapeutics Inc (TENX)$73.77MN/AN/A0.0%N/A0.0%0.00%
    Voyager Therapeutics Inc (VYGR)$107.66MN/A4.0x0.0%N/A-70.0%0.00%
    Gain Therapeutics Inc (GANX)$46.31MN/AN/A0.0%-170.5%-100.0%0.00%
    XBiotech Inc (XBIT)$59.76MN/AN/A0.0%N/A-93.3%0.00%
    TuHURA Biosciences Inc (HURA)$88.58MN/AN/A0.0%-81.8%0.0%0.00%
    Pmv Pharmaceuticals Inc (PMVP)$95.93MN/AN/A0.0%N/A0.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Cognition Therapeutics Inc (CGTX)$64.65MN/AN/A0.0%N/A0.0%0.00%
    OUTLOOK THERAPEUTICS INC (OTLK)$100.54MN/AN/A0.0%-776.9%-99.4%0.00%
    Peer median$76.68MN/A3.0x0.0%-473.7%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to vTv Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Tiziana Life Sciences Ltd (TLSA)
    Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat...
    Tenaya Therapeutics Inc (TNYA)
    Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary...
    TNYA competitors
    Unicycive Therapeutics Inc (UNCY)
    Unicycive Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on pioneering therapies for kidney diseases...
    UNCY competitors
    Tenax Therapeutics Inc (TENX)
    Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing...
    TENX competitors
    Voyager Therapeutics Inc (VYGR)
    Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases.
    VYGR competitors
    Gain Therapeutics Inc (GANX)
    Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding.
    GANX competitors
    XBiotech Inc (XBIT)
    XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases.
    XBIT competitors
    TuHURA Biosciences Inc (HURA)
    TuHURA Biosciences Inc is a pioneering biotechnology firm committed to advancing immunotherapy solutions for cancer and autoimmune diseases.
    HURA competitors
    Pmv Pharmaceuticals Inc (PMVP)
    PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53...
    PMVP competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Cognition Therapeutics Inc (CGTX)
    Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting...
    CGTX competitors
    OUTLOOK THERAPEUTICS INC (OTLK)
    Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic...
    OTLK competitors

    Frequently Asked Questions About VTVT

    Who are vTv Therapeutics' main competitors?

    The companies most similar to vTv Therapeutics include Tiziana Life Sciences (TLSA), Tenaya Therapeutics (TNYA), Unicycive Therapeutics (UNCY), Tenax Therapeutics (TENX) and Voyager Therapeutics (VYGR), listed from the closest match.

    Who is vTv Therapeutics' biggest competitor?

    Voyager Therapeutics (VYGR) is the largest of the similar companies at $107.66M; Tiziana Life Sciences (TLSA) is the closest match by business profile, size, sector and industry.

    How does VTVT stock compare with its competitors?

    VTVT's net margin is -20.8% against a peer median of 0.0%.

    Which of vTv Therapeutics' competitors pays a higher dividend?

    vTv Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is vTv Therapeutics bigger than its competitors?

    No. vTv Therapeutics is 7th by market cap among the 13 companies on this page; the largest is Voyager Therapeutics (VYGR) at $107.66M.